title: A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients.
authors.affiliation: Pharmacy Department, Santa Lucía University Hospital, Cartagena, Spain.
authors.forename: Rocío
authors.initials: R
authors.lastname: Gutiérrez-Cívicos
authors.affiliation: Hematology and Medical Oncology Department, University Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, Murcia, Spain.
authors.forename: Ana María
authors.initials: AM
authors.lastname: Hurtado
authors.affiliation: Pathology Department, Santa Lucía University Hospital, Cartagena, Spain.
authors.forename: Daniel
authors.initials: D
authors.lastname: Torres-Moreno
authors.affiliation: Hematology and Medical Oncology Department, University Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, Murcia, Spain.
authors.forename: José Javier
authors.initials: JJ
authors.lastname: Sanchez-Blanco
authors.affiliation: Hematology Department, Santa Lucía University Hospital, Cartagena, Spain.
authors.forename: Ignacio
authors.initials: I
authors.lastname: Español
authors.affiliation: Statistical Consulting Unit, Cardiology Department, Santa Lucía University Hospital, Cartagena, Spain.
authors.forename: Luciano
authors.initials: L
authors.lastname: Consuegra-Sánchez
authors.affiliation: Hematology and Medical Oncology Department, University Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, Murcia, Spain.
authors.forename: Elena
authors.initials: E
authors.lastname: Perez-Ceballos
authors.affiliation: Hematology Department, Santa Lucía University Hospital, Cartagena, Spain.
authors.forename: María Dolores
authors.initials: MD
authors.lastname: Gutiérrez-Meca
authors.affiliation: Hematology and Medical Oncology Department, University Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, Murcia, Spain.
authors.forename: Andrés
authors.initials: A
authors.lastname: Jerez
authors.affiliation: Clinical Analysis Department, Santa Lucía University Hospital, Universidad Católica de Murcia (UCAM), Cartagena, Spain.
authors.forename: Pablo
authors.initials: P
authors.lastname: Conesa-Zamora
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D053222:Fas Ligand Protein / Q000235:genetics*; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D000071185:Pharmacogenomic Testing; D020641:Polymorphism, Single Nucleotide; D000069283:Rituximab / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000074322:Antineoplastic Agents, Immunological; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D000069283:Rituximab